Skip to main content

Comstock Inc

For the period ended Sep 30, 2024. Filed Oct 22, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 22, 2024

LODE$1.67-13.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Nine-Months Ended
September 30,
20242023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)$(30,565,175)$2,554,833
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization1,833,8781,979,740
Amortization of finance leases36,85332,960
Amortization on discount associated with finance leases16,445229,425
Amortization of debt discount and other debt-related items1,178,105659,743
Accretion of reclamation liability308,276282,119
Interest expense paid with common stock384,241152,877
Impairment of intangible assets8,667,869—
Impairment of properties, plant and equipment324,047—
Research and development expense paid with common stock1,208,180—
Gain on write-off of SSOF deposits(400,000)—
Gain on sale of Facility—(7,304,570)
Gain on investments—(13,309,875)
Loss on extinguishment of debt744,256—
Loss (gain) on conversion of debt3,690,760(51,856)
Employee and director share based compensation (recapture)142,482(67,605)
Change in fair value of derivative instruments(516,756)105,964
Loss on Pelen option—150,000
Share of net loss of equity-method investments1,675,0691,337,801
Other(392,318)(34,357)
Changes in operating assets and liabilities:
Prepaid expenses(149,362)(165,780)
Deposits - asset—289,485
Other assets310,055428,264
Accounts payable1,510,114(320,236)
Accrued expenses, other liabilities and deposits(1,902)581,456
Deferred revenue1,900—
Other liabilities374,9981,285,628
Net cash used in operating activities(9,617,985)(11,183,984)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of mineral rights and properties, plant and equipment(804,949)(1,515,553)
Proceeds from sale of leased facility and related assets—21,000,000
Purchase of Aqua Metals Transfer LLC and Facility—(12,000,000)
Proceeds from sale of ABTC common shares—5,365,981
Proceeds from sale of Green Li-ion preferred shares—779,600
Payments on contractual commitments associated with derivatives(2,464,364)(5,625,000)
Advances to Sierra Springs Opportunity Fund, Inc.—(1,470,000)
Investment in SSOF(530,000)—
Acquisition of intangible asset(100,000)—
Funding of RenFuel note receivable(1,350,000)—
Advances to GenMat(1,235,636)—
Funding of reclamation bond(274,711)—
Other(103,000)(77,642)
Net cash provided by (used in) investing activities(6,862,660)6,457,386
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on financing leases(75,195)(377,114)
Proceeds from the issuance of common stock7,213,7106,350,000
Principal payments of debt(850,000)—
Issuances of debt8,000,000—
Distribution paid to AQMS—(70,355)
Debt issuance costs(90,000)—
Common stock issuance costs(140,120)(257,620)
Net cash provided by financing activities14,058,3955,644,911
Net increase (decrease) in cash and cash equivalents(2,422,250)918,313
Cash and cash equivalents at beginning of period3,785,5772,521,772
Cash and cash equivalents at end of period$1,363,327$3,440,085
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common shares for debt conversion and accrued interest$9,523,870$4,499,598
Issuance of common shares for Northern Comstock LLC mineral rights payments$482,500$482,500
Issuance of common shares with debt$385,875$—
Investment acquired with payable$1,285,961$—
Issuance of common shares for due diligence and commitment fees$85,000$350,000
Issuance of common stock in lieu of payment of marketing expense$162,693$—
Issuance of common stock for Haywood lease amendment$509,850$—
Issuance of common stock for AST lease amendment$378,845$—
Fair value of common stock held by GenMat transferred to GenMat Advances (see Note 2)$694,970$—
Right of use asset and liability due to building operating lease$4,567,814$213,925
Transfer of derivative liability to accrued expenses$3,243,853$—
Return of common stock in connection with conversion of debt and accrued interest$—$(287,049)
Investment shares received on sale of Facility$—$9,365,000
Return of investment shares in lieu of escrowed funds$—$(1,500,000)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.